Hold at neutral weight; wait for tape to resolve at $142.63 200 SMA before adding
This is a "wait for confirmation" stock, not a "buy and hope" stock. The structural quality (dividend Aristocrat status, 53.2% gross margins, $3.71B TTM FCF, sub-2x leverage) justifies patience, the broken technical setup (two failed bounces at $152, expanding negative MACD) prevents new capital deployment, and the 9/16/2026 EMR reflection confirms that the moderating setup type rewards Hold over aggressive trim. Let the tape resolve at the 200 SMA — either successful defense with MACD turning positive (add trigger) or decisive break on volume (exit trigger).
The pullback to $147 represents a gift, not a warning — the 200 SMA support is holding, FCF is accelerating, and the forward P/E of 20.3x is a discount to fair value for a software-flavored industrial with AI-linked end markets.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | $149.16 | bearish |
| 50 SMA | $150.52 | bearish |
| 200 SMA | $142.63 | bullish |
| RSI | 43.13 | neutral |
| MACD | -1.61 | bearish |
| MACD Signal | -0.72 | bearish |
| MACD Histogram | -0.90 | bearish |
| ATR | 3.90 (~2.6% of price) | neutral |
| VWMA | $149.87 | bearish |
| Bollinger Middle Band | $151.97 | neutral |
| Bollinger Upper Band | $159.96 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
↩ rebuts: “Bear is ignoring the print while focusing on 11% off the highs”
EV: Target $165 (prior high); ~12% upside vs ~3% downside risk (4:1 reward-to-risk); stop at $142.50 · concedes: MACD is negative and expanding (-0.90 histogram); RSI at 43 indicates short-term weakness; VWMA confirms selling pressure; Two failed bounces at $152.82 and $152.19 marked attempts to reclaim 50 SMA that failed; Short-term momentum is bearish
EMR is a falling knife, not a buying opportunity — the stock exhibits a textbook distribution pattern with failed bounces, negative momentum indicators, premium valuation requiring execution perfection from a company growing at 3% annually, and is dangerously close to the 200 SMA tripwire in a restrictive macro environment where peer leaders are already derating.
· concedes: Q3 FY2026 reported numbers (revenue up 6.6% QoQ, EPS up 16% QoQ) are real improvements sequentially; Net debt did decline $1.08B year-over-year; The 200 SMA at $142.63 does represent a technical reference point; Software mix and ARR model from AspenTech do provide some stickiness vs. pure cyclical industrial peers
→ vs conservative: EMR trades at 20.3x forward P/E, in line with S&P 500 average, not expensive given 90% sequential FCF growth and 16% sequential EPS growth—treating it like a 'stalled industrial' ignores the quarterly trajectory
→ vs conservative: Peer derating argument using Vertiv (-36%) and Eaton (41.5x) is 'lazy'—EMR's diversified revenue mix is fundamentally different from pure-play AI data-center power plays
→ vs conservative: Two failed bounces at $152 create a coiled spring base, not a broken chart—RSI at 43 pressing toward sub-40 historically marks reversals, not capitulation
→ vs neutral: 'Wait for $150.52 break on volume' add trigger is 'conservative psychology dressed up as discipline'—paying transaction costs for 3% higher confirmation when fundamentals already confirmed in Q3
→ vs neutral: Institutional framing is constructive with estimate upgrades, thematic positioning as Dividend Aristocrat in AI buildout, and 10% recession probability means soft-landing backdrop is intact for capex-driven end markets
→ vs conservative: Everything outside the price chart is pointing bullish—falling 10-year yields are a tailwind for industrial multiples that conservative stance completely discounts
| neutral |
| Bollinger Lower Band | $143.98 | neutral |
Support: 146.9 · 143.98 · 142.63 | Resistance: 149.16 · 150.52 · 151.97
EMR closed at $147.40 on 2026-09-17 with a day's range of $146.90–$149.36 and volume of 2,006,393. The stock has declined roughly 11% from its August 12 peak of $163.25, forming a pattern of lower highs and lower lows. While the long-term trend remains bullish (price above 200 SMA at $142.63), the short-term setup is bearish with price below the 10 EMA, 50 SMA, and VWMA — confirming selling pressure on a volume-weighted basis. RSI at 43.13 is weak but not oversold, and MACD histogram at -0.90 shows expanding bearish momentum. Key support is at $143.98 (Bollinger lower band) and $142.63 (200 SMA), while resistance sits at $149.16 (10 EMA) and $150.52 (50 SMA). The recommendation is HOLD.
Market Capitalization
$82.22 billion
P/E (TTM)
32.32x
Forward P/E
20.34x
PEG Ratio
1.68x
P/B
4.03x
EV/EBITDA
~15.4x
Dividend Yield
1.52%
FCF Yield
~4.5%
Revenue (TTM)
$18.64B
Gross Profit (TTM)
$9.91B
Operating Margin (TTM)
26.92%
EBITDA (TTM)
$6.06B
Net Income (TTM)
$2.58B
EPS (TTM)
$4.56
Forward EPS
$7.25
ROE
12.80%
ROA
6.90%
Revenue Growth (FY2024-2025)
+3.0%
Revenue Growth (FY2024)
+15.3%
EPS Growth (Forward implied)
~60%
Total Assets
$42.21B
Total Liabilities
$21.81B
Stockholders' Equity
$20.38B
Total Debt
$13.26B
Cash & Equivalents
$2.18B
Net Debt
$10.93B
Goodwill & Intangibles
$26.81B (63.5% of assets)
Tangible Book Value
-$6.43B
Working Capital
-$1.12B
Current Ratio
0.896
Debt/Equity
67.7%
TTM Free Cash Flow
$3.71B
TTM Operating Cash Flow
~$3.91B
FCF/Net Income
1.44x
CapEx (FY2025)
$431M
Dividends (FY2025)
$1.19B
Buybacks (FY2025)
$1.17B
Total Shareholder Yield
~3.0-3.5%
Share Count
558M
52-Week High
$166.35
52-Week Low
$122.64
50-Day Moving Average
$150.56
200-Day Moving Average
$143.44
Beta
1.233
Gross Margin (FY2025)
52.8%
Operating Margin (FY2025)
19.6%
Net Margin (FY2025)
12.7%
Strengths
Concerns
Emerson Electric has completed a major strategic transformation, divesting legacy businesses and positioning as a focused automation franchise with best-in-class 53% gross margins and strong free cash flow generation of $3.71B annually. The company's valuation (Forward P/E 20.34x) reflects expectations for ~60% EPS growth driven by software recurring revenue ramp, restructuring savings, and ongoing margin expansion, though the TTM P/E of 32.32x demands continued execution on NI/AspenTech integration. With net debt deleveraging to $10.93B and ~$2.4B annual shareholder returns, EMR offers favorable risk/reward for investors seeking quality industrial exposure with growth characteristics.
Macro: FRED API unavailable; macro read grounded in news flow and Polymarket. Fed appears to be hiking or holding restrictive (Barron's 'loving rate hike' framing). 10Y Treasury easing. Oil ~$100 (falling but inflation-supportive). AI capex cycle intact (IBM-CHIPS, Lockheed AI, IBM-IonQ). No recession signal in base case: US recession probability 10% (+1.0pp WoW), UK 10% (+4.5pp WoW), Japan 6% (+0.5pp WoW). Fed path: 95% probability of zero cuts in 2026 (+2.7pp WoW).